| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| BO Brian Oliveira Clear Street Group Inc. | 472,128 | $18,421.27 | $23,606.4 | $5,185.13 | 28.15% |
| LV Lindsay Voak Greenland Capital Management LP | 30,799 | $1,139.57 | $1,539.95 | $400.38 | 35.13% |
| Software Industry | Information Technology Sector | Michel Brousset CEO | NASDAQ (CM) Exchange | G9503X111 CUSIP |
| US Country | 335 Employees | - Last Dividend | 28 Jul 2022 Last Split | 11 May 2021 IPO Date |
Waldencast Acquisition Corp. is a prominent entity in the skincare industry, primarily known for its innovative approach to advanced skincare treatments. Established in 1988 and based in White Plains, New York, the company has carved a niche for itself by focusing on products that combat the signs of premature skin aging, damage due to sun exposure, hyperpigmentation, acne, and other skin concerns. These products are widely available and endorsed by dermatologists, plastic surgeons, medical spas, and skincare professionals, ensuring they reach those in need of professional-grade skincare solutions.
Waldencast Acquisition Corp. boasts a diverse portfolio through its key brands, Obagi Medical and Obagi Clinical, each designed to cater to specific skin health needs: